Category: Johnson & Johnson
Johnson & Johnson's LifeScan business plans a clinical trial to test a mobile app for its OneTouch Verio Flex blood glucose meter.
Johnson & Johnson revives the Kilmer Conference on sterility assurance and sterilization after a series of high-profile - and sometimes deadly - 'superbug' infections.
Johnson & Johnson (NYSE:JNJ) said today that it's planning to revive the sterility assurance and sterilization conference it ran for 27 years before closing up shop in 2003.
Here's a look at some of the top legal news stories for medical device companies this week: Witness for J&J's Synthes faked credentials; Medtronic agrees to stop making SynchroMed drug pump; NuVasive settles Justice Dept. probe for $14m; Boston Scientific inks $119m pelvic mesh deal; Stryker inks $3m settlement in Howmedica reimbursement suit
, Centers for Medicare and Medicaid Services (CMS)
, Dept. of Health & Human Services (HHS)
, Dept. of Justice (DOJ)
, DePuy Synthes Spine
, Food & Drug Administration (FDA)
, Globus Medical
, Howmedica Osteonics Corp.
, Johnson & Johnson
Globus Medical wants a federal judge to toss its $16 million loss to Johnson & Johnson's Synthes division because a key expert witness faked his credentials.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Feds slap former Acclarent execs with fraud charges; Zimmer extends deadline for $13B Biomet deal; Big data: IBM enlists Medtronic, J&J, Apple in major healthcare push
, Acclarent Inc.
, Ethicon Inc.
, Federal Trade Commission (FTC)
, Johnson & Johnson
, NxThera Inc.
IBM unveils a major push to use 'Big Data' and its Watson supercomputer to drive healthcare research and personalized medicine, enlisting Medtronic, Johnson & Johnson and Apple to help.
The strong dollar pares a 13% chunk out Johnson & Johnson's 1st-quarter sales, prompting a lowered earnings outlook, but the healthcare giant still manages to beat Wall Street's estimate.